AkhtarAshfaqMDFACP, FASN

Nephrology • Miami, FL

Chronic Renal Failure & Dialysis, Hypertension, Renal Metabolism

Senior Vice President, Clinical R&D and Medical Affairs, OPKO Renal, Division of OPKO Pharmaceuticals, Miami, Florida

Join to view full profile

Dr. Ashfaq is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ashfaq's full profile

Already have an account?

Office
4400 Biscayne Blvd
Miami, FL 33137
Phone+1 516-810-8680

Fax+1 516-810-8680

Education & Training

Zucker School of Medicine at Hofstra/NorthwellFellowship, Nephrology, 1994 - 1996
TriHealth (Good Samaritan Hospital)Residency, Internal Medicine, 1991 - 1994
Dow University of Health SciencesClass of 1988

Certifications & Licensure

FL State Medical License 2020 - 2026
NY State Medical License 1995 - 2026
PA State Medical License 1996 - 2000

Clinical Trials

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism Start of enrollment: 2023 Jan 31
Recruiting
Phase 3
Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 Start of enrollment: 2020 Nov 02
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyper...
Charles W Bishop, Akhtar Ashfaq, Stephen A Strugnell, John Choe, Nilay Patel
American Journal of Nephrology. 2024-08-27
Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism.
Domenico Merante, Henrik Schou, Isabelle Morin, Marius Manu, Akhtar Ashfaq
Nephron. 2024-01-01
3 citations
Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease.
Stephen A Strugnell, Philipp Csomor, Akhtar Ashfaq, Charles W Bishop
Kidney Diseases. 2023-05-01

Authored Content

Tubulointerstitial Nephritis and Uveitis Syndrome (TINU Syndrome)September 2022